The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide
range of incurable diseases. Recent rapid advances in biotechnology and molecular …

Safety and effectiveness of COVID-19 vaccines during pregnancy is a particular concern
affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 …

With the constantly mutating of SARS-CoV-2 and the emergence of Variants of Concern
(VOC), the implementation of vaccination is critically important. Existing SARS-CoV-2 …

Background Infants younger than 6 months of age are at high risk for complications of
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental …

Importance Pregnant women were excluded from the BNT162b2 messenger RNA (mRNA)
COVID-19 vaccine (Pfizer-BioNTech) preauthorization trial. Therefore, observational data on …

Objectives To determine the immunogenicity and reactogenicity of the Pfizer/BioNTech
BNT162b2 mRNA coronavirus disease 2019 (COVID‐19) vaccine among pregnant women …

ABSTRACT The coronavirus disease 2019 (COVID-19), which is caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has precipitated a global health crisis of …

Pregnant and lactating women (PLW) represent a particular population subset with
increased susceptibility for COVID-19 morbidity and mortality, even though the evidence …

Pregnancy is an independent risk factor for severe covid-19. Vaccination is the best way to
reduce the risk for SARS-CoV-2 infection and limit its morbidity and mortality. The current …

Methods| The study included individuals who had received an mRNA COVID-19 vaccine in
pregnancy or were infected with SARS-CoV-2 at 20 to 32 weeks' gestation, had enrolled in a …